Continuing Education

Accreditation with Commendation

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Swedish Medical Center and the Society for the Advancement of Blood Management. Swedish Medical Center is accredited by the ACCME to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

Swedish Medical Center designates this educational activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Target Audience
  • Anesthesiologists
  • Critical Care Specialist
  • Hematologists
  • Pediatricians
  • Cardiologists
  • Intensive Care Specialists
  • Oncologists
  • Transfusion Medical Specialists
  • Surgeons
  • Perfusionists
  • Health Care Administrators
  • Hospitalists
  • Health-System Pharmacists
  • Blood Management/Conservation Program Managers
Course Goal

The principal goal of this course is to educate attendees in blood management, which includes the better use of blood products, blood conservation and transfusion alternatives in everyday clinical practice using evidence based and/or consensual approach.

Learning Objectives
  • Define the appropriate and safe use of ESA's in the anemic patient in 2009
  • Demonstrate ways that good Patient Blood Management can be utilized in an obstetric service
  • Explain how blood centers play a role in the future of patient blood management
  • Define the options available in treatment for the patient who refuses blood transfusion but may benefit from a hematology consult
  • Demonstrate data that shows outcomes in the patient population having open heart surgery with little or no transfusion
SABM Needs Assessment:
Problem Objective
Confusion exists in the US since the beginning of 2008 regarding the appropriate safe use of erythropoietic stimulating agents (ESA's) to treat anemia
Ref: Continued Challenges with the Use of Erythopoiesis-Stimulating Agents in Patients with Cancer: Perspectives and Issues on Policy-Guided Health Care, Arbuckle R, Griffith N, Iacovelli L, Johnson P, Jorgenson J, Kloth D, Lucarelli C, Muller R. Pharmacotherapy 2008
Ref: Meta-Analysis Confirms Mortality Risk of ESAs in Cancer Patients. Advisroy.com 2008
Ref: CMS Proposes Limiting Coverage of Anemia Drugs Amid Safety Concerns. Advisory.com 2008 		Define the appropriate and safe use of ESA's in the anemic patient in 2009
In the bleeding Obstetric patient it is not possible to institute transfusion reduction safely
Ref: Blood Component Therapy in Obstetrics, Fuller A, Bucklin B. Obstet Gynecol Clin N Am 2007
Ref: Postpartum Hemorrhage, Oyelese Y, Scorza W, Mastrolia R, Smulian J. Obstet Gynecol Clin N Am 2007
Ref: ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists. Obstetrics & Gynecology 2006		 Demonstrate ways that good Patient Blood Management can be utilized in a Obstetric service
Blood Centers have appeared to play a limited role in the support of the hospital based Blood Management programs in the Pacific Northwest region.
Ref: The Transfusion Committee: Putting Patient Safety First (AABB Press, Bethesda, MD, 2006
Ref: Joint Commission Perspectives on Patient Safety, January 2007, Vol 7, Issue 1
Ref: America finds hemovigilance! AuBuchon, J P; Whitaker, B I. Transfusion 2007;47:1937-1942 		Explain how blood centers play a role in the future of patient blood management.
Patients may refuse consent for transfusions, creating significant ethical concerns for treating hematologists.
Reference: Stowell CS, Sazama K, eds. Informed Consent…, AABB Press, Bethesda, MD, 2008		 Define the options available in treatment for the patient who refuses blood transfusion but may benefit from a hematology consult.
Reducing transfusion in open heart surgery is dangerous.
Ref: Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001 Oct 25;345(17):1230-6.		 Demonstrate data that shows outcomes in the patient population having open heart surgery with little or no transfusion.